Background: Atrial fibrillation is associated with increased but variable risk of stroke. Our aim
was to validate the recently developed biomarker-based ABC (age, biomarkers [high …

Background The ABC‐stroke score (age, biomarkers [N‐terminal fragment B‐type natriuretic
peptide, high‐sensitivity troponin], and clinical history [prior stroke/transient ischemic attack]) …

Aims Atrial fibrillation (AF) is associated with an increased risk of stroke, which is currently
estimated by clinical characteristics. The cardiac biomarkers N-terminal fragment B-type …

Background Cardiac biomarkers are independent risk markers in atrial fibrillation, and the
novel biomarker–based ABC stroke score (age, biomarkers, and clinical history of prior …

Background: Previous studies report that CHADS2 and CHA2DS2-VASc risk scores have
similar discriminating ability (C statistic∼ 0.6). Recently a clinically based risk score, the …

2666 Stroke October 2017 validation studies showed fair-to-good predictive ability of the
CHADS2 score, with C statistics ranging between 0.56 and 0.82. 18 Despite these validation …

Abstract Purpose of Review Stroke prevention is the cornerstone of atrial fibrillation (AF)
management and the anticoagulation decision is currently based on CHA 2 DS 2-VASc risk …

Aim To assess the risk of stroke and thromboembolism in patients with atrial fibrillation (AF)
based on risk factor combinations of the CHA2DS2-VASc score. Methods and results Using …

Background and Purpose—Current European guidelines for the management of atrial
fibrillation suggest using biomarkers to refine the risk stratification process. However, it is …

Aims Multiple risk scores to predict ischaemic stroke (IS) in patients with atrial fibrillation (AF)
have been developed. This study aims to systematically review these scores, their …